Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Hank Lockman"'
Autor:
Jennifer A. Woyach, John C. Byrd, Rosa Lapalombella, Hank Lockman, Samantha M. Jaglowski, Seema Bhat, Kerry A. Rogers, Renee Vadeboncoeur, Harsh Shah, Boyu Hu, Sharyn Baker, Qiang Fu, Casey B. Cempre, Daniel Canfield, Janek S. Walker, Amy S. Ruppert, Ying Huang, Deborah M. Stephens
Purpose:Dual blockade of Bruton's tyrosine kinase with ibrutinib and selinexor has potential to deepen responses for patients with chronic lymphocytic leukemia (CLL) and non-Hodgkin lymphoma (NHL).Patients and Methods:In this phase I study (clinicalt
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5473c10baa71f18bffb8e5cd70446661
https://doi.org/10.1158/1078-0432.c.6532472.v1
https://doi.org/10.1158/1078-0432.c.6532472.v1
Autor:
Jennifer A. Woyach, John C. Byrd, Rosa Lapalombella, Hank Lockman, Samantha M. Jaglowski, Seema Bhat, Kerry A. Rogers, Renee Vadeboncoeur, Harsh Shah, Boyu Hu, Sharyn Baker, Qiang Fu, Casey B. Cempre, Daniel Canfield, Janek S. Walker, Amy S. Ruppert, Ying Huang, Deborah M. Stephens
Supplementary Data from Selinexor Combined with Ibrutinib Demonstrates Tolerability and Safety in Advanced B-Cell Malignancies: A Phase I Study
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::565e835c784f23a218be444c7afaed07
https://doi.org/10.1158/1078-0432.22487252
https://doi.org/10.1158/1078-0432.22487252
Autor:
Deborah M. Stephens, Ying Huang, Amy S. Ruppert, Janek S. Walker, Daniel Canfield, Casey B. Cempre, Qiang Fu, Sharyn Baker, Boyu Hu, Harsh Shah, Renee Vadeboncoeur, Kerry A. Rogers, Seema Bhat, Samantha M. Jaglowski, Hank Lockman, Rosa Lapalombella, John C. Byrd, Jennifer A. Woyach
Publikováno v:
Clin Cancer Res
Purpose: Dual blockade of Bruton's tyrosine kinase with ibrutinib and selinexor has potential to deepen responses for patients with chronic lymphocytic leukemia (CLL) and non-Hodgkin lymphoma (NHL). Patients and Methods: In this phase I study (clinic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6bb3abaeb2ff7dd5e988afc9c30a17a8
https://doi.org/10.1158/1078-0432.ccr-21-3867
https://doi.org/10.1158/1078-0432.ccr-21-3867
Autor:
Hank Lockman, P.F. Fellows, Roy E. Barnewall, Mary Kate Hart, Shannon S. Martin, Karen Metcalfe, Robert Krile, Jessica Price
Publikováno v:
Clinical and Vaccine Immunology. 22:1070-1078
The efficacy of a recombinant plague vaccine (rF1V) was evaluated in cynomolgus macaques (CMs) to establish the relationship among vaccine doses, antibody titers, and survival following an aerosol challenge with a lethal dose of Yersinia pestis strai
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6b66a9f5349fb4e0883717a1b58db1c7
https://doi.org/10.1128/cvi.00290-15
https://doi.org/10.1128/cvi.00290-15
Publikováno v:
Human Antibodies. 16:99-105
ALXN4100, a fully human antibody that binds to the protective antigen of anthrax toxin, was generated from a Fab isolated from a phage display library and was analyzed for its pharmacokinetic properties in rabbits and then used to protect rabbits fro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1deb5b394328a733314ad91231c788a1
https://doi.org/10.3233/hab-2007-163-404
https://doi.org/10.3233/hab-2007-163-404
Autor:
Hank Lockman, Robert V. House, Robert Krile, Jessica Price, Daphne Vasconcelos, Mark A. Bolanowksi, P.F. Fellows, Roy E. Barnewall, Richard L. Warren, Oscar Bermeo Blanco
Publikováno v:
Microbial pathogenesis. 50(1)
A recombinant vaccine (rF1V) is currently being developed for protection against pneumonic plague. An essential component in evaluating efficacy of the rF1V vaccine is the development of a well-understood animal model that shows similarity to human d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2474e3cd08df044885cbe5c9b65edae8
https://pubmed.ncbi.nlm.nih.gov/21040776
https://pubmed.ncbi.nlm.nih.gov/21040776
Autor:
Roy E. Barnewall, Carol L. K. Sabourin, Ling Shen, Zahida Ali, Hassan Jomaa, James Eestep, Lingyun Shao, Martin Hintz, Dan Huang, Hank Lockman, Zheng W. Chen, Richard Wang, Crystal Y. Chen, Armin Reichenberg
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America. 106(18)
The possibility that Vγ2Vδ2 T effector cells can confer protection against pulmonary infectious diseases has not been tested. We have recently demonstrated that single-dose ( E )-4-hydroxy-3-methyl-but-2-enyl pyrophosphate (HMBPP) plus IL-2 treatme
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d650c92495dc29044c761c61886ceee6
https://pubmed.ncbi.nlm.nih.gov/19383786
https://pubmed.ncbi.nlm.nih.gov/19383786